|
|
Gene Symbol |
EDN1 |
|
Aliases |
ARCND3, ET1, HDLCQ7, PPET1, QME |
|
Entrez Gene ID |
|
|
Gene Name |
Endothelin 1 |
|
Chromosomal Location |
6p24.1 |
|
HGNC ID |
|
|
Summary |
This gene encodes a preproprotein that is proteolytically processed to generate a secreted peptide that belongs to the endothelin/sarafotoxin family. This peptide is a potent vasoconstrictor and its cognate receptors are therapeutic targets in the treatment of pulmonary arterial hypertension. Aberrant expression of this gene may promote tumorigenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
Endothelin-1, preproendothelin-1 |
|
Function |
Endothelins are endothelium-derived vasoconstrictor peptides |
|
|
|
|
|
UniProt |
|
|
PDB |
|
|
Pfam |
Pfam Accession |
Pfam ID |
PF00322 |
Endothelin |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000362727 |
|
Q8TEH3 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Cardiovascular Diseases |
Hypertensive disease |
12425201, 15314687, 11847185, 12149661, 12600921, 15188945, 10669576, 17130675, 15834289, 10474778, 8440307, 8152482, 15302986, 7721406 |
Heart Failure |
|
Myocardial Ischemia |
|
Cardiomyopathy |
|
Myocardial Failure |
|
Atrial Fibrillation |
|
Cardiovascular Abnormalities |
|
Left Ventricular Hypertrophy |
|
Myocardial Diseases |
|
Arteriosclerosis |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Auriculocondylar Syndrome |
|
Hemorrhages |
|
Digestive System Diseases |
Hepatorenal Syndrome |
|
Peptic Ulcer |
|
Cholera Infantum |
|
Gastrointestinal Diseases |
|
Marginal ulcer |
|
Oral ulcer |
|
Endocrine System Diseases |
Diabetes Mellitus |
|
PCOS |
|
Musculoskeletal Diseases |
Cartilage Diseases |
|
Chondromalacia |
|
Nervous System Diseases |
Stroke |
|
Parkinson Disease |
|
Cerebrovascular Occlusion |
|
Middle Cerebral Artery Syndrome |
|
Cerebrovascular Insufficiency |
|
Cerebral Artery Infarction |
|
Brain Infarction |
|
Cerebral Thrombosis |
|
Cerebrovascular Disorders |
|
Nutritional and Metabolic Diseases |
Hypercholesterolemia |
|
Psychiatric/Brain disorders |
Lewy Body Disease |
|
Mood Disorders |
|
Obstructive Sleep Apnea |
|
Renal Disorder |
Overactive Bladder |
|
Kidney Failure |
|
Glomerular Hyalinosis |
|
Kidney Insufficiency |
|
Nephrosis |
|
Glomerulosclerosis |
|
Reproductive disorders |
Preeclampsia |
|
Respiratory Tract Diseases |
Pulmonary Fibrosis |
|
Asthma |
|
Respiratory Distress Syndrome |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
Endothelin-2 |
|
|
Rotterdam criteria |
Related
|
|
GLCs from women with PCOS, Endothelin-1 mRNA expression was elevated (2.2-fold) as compared with normally ovulating women, whereas endothelin-2 mRNA was reduced (1.8-fold) |
|
|
Endothelial dysfunction |
|
NIH criteria |
Related
|
|
ET-1 levels were positively and strongly associated with AGEs in both PCOS women and controls, suggesting that the detrimental effect of AGEs on endothelial cells may involve increased ET-1 production |
|
C-reactive protein |
Cardiovascular risk factors |
|
|
Related
|
|
ET-1 levels were higher in PCOS patients compared to controls |
|
CRP |
Cardiovascular risk |
|
|
Related
|
|
ET1 was significantly higher in PCOS women compared to controls |
|
ADMA |
Endothelial dysfunction |
|
|
Related
|
|
ET-1 and ADMA concentrations were higher in women with PCOS, and they were positively correlated with each other. |
|
hsCRP,soluble ICAM-1,soluble VCAM-1,SHGB |
Hyperandrogenaemia |
|
|
Related
|
|
The present study demonstrates that endothelial dysfunction coexists and is influenced by the presence of increased serum levels of inflammation and endothelial activation markers in young women with PCOS. |
|
|
Endothelial dysfunction |
|
|
Related
|
|
PCOS women were found to exhibit endothelial dysfunction compared with controls |
|
|
Hyperandrogenemia, hyperinsulinemia,endothelial dysfunction and insulin resistance |
|
NIH criteria |
Related
|
|
Women with polycystic ovary syndrome, obese and nonobese, have elevated endothelin-1 levels compared with the age-matched control group. |
|
Androgens, leptin, fibrinogen, homocysteine, |
Cardiovascular risk |
|
Authors criteria |
Related
|
|
Endothelin-1 was significantly higher in lean controls compared with obese controls and obese PCOS patients |
|
MDA,Apo A1, Apo B,PON1,SHBG,DHEAS |
Insulin resistance, dyslipidemia, endothelial dysfunction,cardiovascular disease and oxidative stress |
|
|
Related
|
|
Significantly decreased SHBG, NO, HDL-C levels, and PON1 activities, but increased tT, fT, androstenedione, DHEAS, HOMA index, MDA, ET-1, LDL-C, sdLDL-C, and LbLDL-C values were found in PCOS patients compared with those of controls. |
|
|
|
|